NDC 63323-489-01 - XYLOCAINE-MPF WITH EPI
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-489
- Requested NDC
- 63323-489-01
- Package NDCs from labels
- 63323-489-02, 63323-489-27, 63323-489-03, 63323-489-21, 63323-489-01, 63323-489-17
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2026-06-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| XYLOCAINE-MPF WITH EPI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2026-06-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - Henry Schein, Inc. | Henry Schein, Inc. | 2025-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
| SODIUM CHLORIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2021-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - A-S Medication Solutions | A-S Medication Solutions | 2019-09-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Cardinal Health | Cardinal Health | 2019-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-489-01 | XylocaineMPF | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 13 | |
| 63323-489-02 | XylocaineMPF | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 13 | |
| 63323-489-03 | XylocaineMPF | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 13 | |
| 63323-489-17 | XylocaineMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-489-21 | XylocaineMPF | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 13 | |
| 63323-489-27 | XylocaineMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-489 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 13 | Current NDC, Legacy NDC, 6 package rows | 20210831_ba082c2f-64f4-419d-9c88-74f203316e17.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-489-01 | ML - Milliliter | 63323-489 | 402305d2-a2ba-4b33-9fa8-ab46fcf60153 | 1 | 2020-04-20 |
| 63323-489-02 | ML - Milliliter | 63323-489 | df03fb66-fedf-4500-b351-a5ca5cb881c6 | 1 | 2020-01-03 |
| 63323-489-03 | ML - Milliliter | 63323-489 | 82287f5e-6d70-4e4e-b6f9-b8aed85aea88 | 1 | 2020-04-20 |
| 63323-489-17 | ML - Milliliter | 63323-489 | 060d2a30-ef0f-4217-b6a1-2b9480814a95 | 1 | 2012-07-24 |
| 63323-489-21 | ML - Milliliter | 63323-489 | 54ff07e7-5f48-4ea2-a418-1a939aa466c1 | 1 | 2012-07-24 |
| 63323-489-27 | ML - Milliliter | 63323-489 | 166479a5-291e-4225-b22f-086cf1193f69 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| QUALITY CHOICE SALINE | SODIUM CHLORIDE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | f51491d8-12ad-4b1b-a171-c621bfdcc341 | 2025-08-12 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Henry Schein, Inc. | e0466bb3-6c26-4044-b051-69f48b67f632 | 2025-08-07 | Adverse reactions | 451W47IQ8X |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Lannett Company, Inc. | c3353e08-2a8c-4ace-ba89-114f7131b8de | 2025-08-07 | Warnings, Adverse reactions | EC2CNF7XFP |
| Xylocaine | LIDOCAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE INJECTION, SOLUTION | Henry Schein, Inc | 9e8d0318-b2fe-4084-aedf-de97f61605a8 | 2025-08-07 | Warnings, Adverse reactions | NDA006488 1010745 1010749 30Q7KI53AK EC2CNF7XFP |
| Schuessler Tissue Salts Nat Mur Fluid Balance 9 | NATRUM MURIATICUM | Martin & Pleasance Pty Ltd | 08da6353-9625-4e8f-8575-a2b49f5d2ac6 | 2025-08-04 | Warnings | 451W47IQ8X |
| Gout Relief 3310-S | CELERY SEED, MEDICAGO SATIVA WHOLE,CHICORY ROOT | Bispit Canada Ltd. | 3afaa7d9-3de3-52d9-e063-6294a90a54ec | 2025-08-02 | Warnings | 451W47IQ8X |
| QUALITY CHOICE SALINE | PLUS SOOTHING ALOE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 4ae4e88a-aaa5-4195-bedc-622fd5cd9394 | 2025-07-30 | Warnings | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | 9e72418a-376e-4637-99ad-d13c904a7986 | 2025-07-30 | Warnings, Adverse reactions | 451W47IQ8X |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 985a3341-0fe0-1dd6-e053-2a95a90ad2c5 | 2025-07-25 | Warnings | 451W47IQ8X |
| Dairy-Grain-Nightshade | IRIS VERS., SOLIDAGO, ANTIMON. CRUD., ARG. NIT., ARSENICUM ALB., AVENA, BAPTISIA, BELLADONNA, BRYONIA, CAPSICUM, CARDUUS BEN., CINCHONA, DULCAMARA, FAGOPYRUM, GELSEMIUM, HYOSCYAMUS, IPECAC., LAC VAC., LACHESIS, LYCOPODIUM, NAT. MUR., PHOS., PODOPH. PELT., PULSATILLA, RHUS TOX., SAC. LAC., SECALE, SEPIA, STRAMONIUM, TABACUM, TRITICUM, USTILAGO MAIDIS, VERBASCUM, LYCOPERSICUM, SOLANUM NIG., SOLANUM TUB., STIGMATA, TORULA CEREVISIAE. | Newton Laboratories, Inc. | 99fcbd61-ecc8-cf9d-e053-2995a90aebeb | 2025-07-25 | Warnings | 451W47IQ8X |
| Bedwetting | ECHINACEA, HYDRASTIS CANADENSIS, PASSIFLORA INCARNATA, VALERIANA OFFICINALIS, BELLADONNA, CANTHARIS, CAUSTICUM, EQUISETUM HYEMALE, FERRUM METALLICUM, GELSEMIUM SEMPERVIRENS, HUMULUS LUPULUS, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, PLANTAGO MAJOR, PULSATILLA, RHUS AROMATICA, SABAL SERRULATA, THYROIDINUM, VERBASCUM THAPSUS | Newton Laboratories, Inc. | 9d5f51d0-01e9-271c-e053-2995a90a63bc | 2025-07-24 | Warnings | 451W47IQ8X |
| Bedwetting | ECHINACEA, HYDRASTIS CANADENSIS, PASSIFLORA INCARNATA, VALERIANA OFFICINALIS, BELLADONNA, CANTHARIS, CAUSTICUM, EQUISETUM HYEMALE, FERRUM METALLICUM, GELSEMIUM SEMPERVIRENS, HUMULUS LUPULUS, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, PLANTAGO MAJOR, PULSATILLA, RHUS AROMATICA, SABAL SERRULATA, THYROIDINUM, VERBASCUM THAPSUS | Newton Laboratories, Inc. | 9d6058a0-69dd-66d0-e053-2a95a90a58f8 | 2025-07-24 | Warnings | 451W47IQ8X |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1b4e96-c96f-6424-e053-2991aa0aef30 | 2025-07-24 | Warnings | 451W47IQ8X |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1a9ef9-9a54-5f94-e053-2a91aa0ab477 | 2025-07-24 | Warnings | 451W47IQ8X |
| Xylocaine | LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE | ProPharma Distribution | 386c23fd-1691-98b2-e063-6294a90ab070 | 2025-07-18 | Warnings, Adverse reactions | NDA006488 1010751 1010755 30Q7KI53AK EC2CNF7XFP |
| BACTERIOSTATIC SODIUM CHLORIDE | SODIUM CHLORIDE | ProPharma Distribution | 3868864f-4f46-d2a1-e063-6394a90a65d5 | 2025-07-18 | Boxed warning, Warnings, Adverse reactions | 451W47IQ8X |
| Aller-Chord F | ACETALDEHYDE, ACETICUM AC, ARG NIT, CAFFEINUM, CALC SULPH, CITRICUM AC, CORTISONE ACETICUM, ECHINACEA PURP, FOLLICULINUM, FRAGARIA, FUMARICUM AC, GALLICUM AC, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRANGEA, LAC VAC, LECITHIN, LIMULUS, LYCOPERSICUM, LYCOPODIUM, NAT BICARB, NAT MUR, NUX VOM, PARAFFINUM, PHOSPHORICUM AC, SACCHARUM OFF, SILICEA, TARTARICUM AC, TORULA CEREVISIAE. | Energetix Corporation | ff4eb7b2-8272-4bd3-99a9-7e589b30d59a | 2025-07-15 | Warnings | 451W47IQ8X |
| HerpaOne | GRAPHITE, SODIUM CHLORIDE, SYMPHYTUM OFFICINALE WHOLE, THUJA OCCIDENTALIS LEAFY TWIG | Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions | 6b196d97-6446-4651-97ef-6615cf3e3173 | 2025-07-11 | Warnings | 451W47IQ8X |
| POTASSIUM CHLORIDE IN SODIUM CHLORIDE | SODIUM CHLORIDE AND POTASSIUM CHLORIDE | B. Braun Medical Inc. | ecc38772-246a-46c4-b42a-b9b81124f27f | 2025-07-11 | Warnings, Adverse reactions | 451W47IQ8X |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 953471e2-9efb-adf0-e053-2a95a90afd95 | 2025-07-09 | Warnings, Adverse reactions | 1010671 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.